Thrombosis of a prosthetic aortic valve during pregnancy despite therapeutic dosage of Nadroparin [9]

Thrombosis and Haemostasis

Volumn 91, Issue 4, 2004, Pages 839-840

  Obergfell, Achim ^a   Langenfeld, Heiner ^b   Hopp, Heiner ^b   Steigerwald, Udo ^b   Grossmann, Ralf ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN; HEPARIN; NADROPARIN;

ADULT; AORTA VALVE PROSTHESIS; BLOOD SAMPLING; CASE REPORT; DOSE RESPONSE; ECHOCARDIOGRAPHY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LETTER; PREGNANCY; PRIORITY JOURNAL; SAINT JUDE HEART VALVE PROSTHESIS; SYMPTOMATOLOGY; THORACIC AORTA ANEURYSM; THROMBOSIS;

EID: 1842788521     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614280     Document Type: Letter

References (15)

1. Lindhoff-Last E, Schinzel H, Erbe M, et al.. Anticoagulation of pregnant women with mechanical heart valve prostheses. Z Kardiol 2001 90 Suppl 6: 125-30.
2. Montalescot G, Polle V, Collet JP, et al.. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000 101: 1083-6.
3. Arnaout MS, Kazma H, Khalil A, et al.. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? Clin Exp Obstet Gynecol 1998; 25: 101-4.
4. Ezekowitz MD. Anticoagulation management of valve replacement patients. J Heart Valve Dis 2002; 11 Suppl 1: S56-60.
5. Ginsberg JS, Chan WS, Bates SM, et al.. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003; 163: 694-8.
6. Messmore HL Jr., Kundur R, Wehrmacher W, et al.. Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparin. Clin Appl Thromb Hemost 1999; 5: 73-7.
7. Golby AJ, Bush EC, DeRook FA, et al.. Failure of high-dose heparin to prevent recurrent cardioembolic strokes in a pregnant patient with a mechanical heart valve. Neurology 1992; 42: 2204-6.
8. Deitelzweig SB, Vanscoy GJ, Niccolai CS, et al.. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Ann Pharmacother 2003; 37: 402-11.
9. Mahesh B, Evans S, Bryan AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: Case report and a review of options for anticoagulation. J Heart Valve Dis 2002; 11: 745-50.
10. Oles D, Berryessa R, Campbell K, et al.. Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: A case report. Perfusion 2001; 16: 159-64.
11. Lev-Ran O, Kramer A, Gurevitch J, et al.. Low-molecular-weight heparin for prosthetic heart valves: Treatment failure. Ann Thorac Surg 2000; 69: 264-5; discussion 265-6.
12. Shapira Y, Sagie A, Battler A. Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol 2002; 25: 323-7.
13. Leyh RG, Fischer S, Ruhparwar A, et al.. Anti-coagulation for prosthetic heart valves during pregnancy: Is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg 2002; 21: 577-9.
14. Lee LH, Liauw PC, Ng AS. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996; 76: 628-30.
15. Barbour LA. Current concepts of anticoagulant therapy in pregnancy. Obstet Gynecol Clin North Am 1997; 24: 499-521.